Summary
IDEXX Laboratories, Inc. (IDXX) filed a Form 8-K on February 2, 2017, to report its financial results for the fourth quarter and full year ended December 31, 2016. The report itself does not contain detailed financial figures but rather directs investors to an accompanying press release (Exhibit 99.1) for the specific results and operational commentary. This filing is typical for companies announcing earnings and serves as the official notification to the SEC, with the detailed financial information being furnished rather than formally filed.
Key Highlights
- 1IDEXX Laboratories announced its financial results for the fourth quarter and full year 2016 on February 2, 2017.
- 2The 8-K filing serves as the official notification of these earnings results to the SEC.
- 3The detailed financial results and operational commentary are provided in an attached press release, Exhibit 99.1.
- 4The information furnished in this report is for the period ending December 31, 2016.
- 5The filing indicates that the accompanying press release is furnished and not deemed 'filed' for certain SEC liability purposes.
- 6Brian P. McKeon, Executive Vice President, Chief Financial Officer and Treasurer, signed the report.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially announce and provide access to IDEXX Laboratories' financial results for the fourth quarter and full year ended December 31, 2016.
The detailed financial results are presented in the press release titled 'IDEXX Laboratories Announces Fourth Quarter and Full Year 2016 Results,' which is furnished as Exhibit 99.1 to this Form 8-K filing.
According to the filing, the information in the 8-K and the accompanying press release (Exhibit 99.1) is being furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, unless expressly incorporated by reference in another filing.
The report is signed by Brian P. McKeon, who holds the positions of Executive Vice President, Chief Financial Officer, and Treasurer for IDEXX Laboratories, Inc., indicating his responsibility for the financial reporting.